HitGen Inc.
HitGen is a Chengdu-based company listed on Shanghai's STAR Market (SSE: 688222), best known for DNA-encoded library drug discovery services. Its own candidate HG146 is in Phase 2 in China.
| Headquarters | Chengdu, China |
|---|---|
| Listing | SSE:688222 |
| Lead asset / stage | HG146 Phase 2 — China |
| Latest event | HitGen published results for the first three quarters of 2026. |